Skip to main content
Top
Published in: Lung 1/2015

01-02-2015

Effects of Exercise and Vasodilators on Cerebral Tissue Oxygenation in Pulmonary Hypertension

Authors: Séverine Müller-Mottet, Florian F. Hildenbrand, Stephan Keusch, Elisabeth Hasler, Marco Maggiorini, Rudolf Speich, Konrad E. Bloch, Silvia Ulrich

Published in: Lung | Issue 1/2015

Login to get access

Abstract

Background

Arterial and thromboembolic pulmonary hypertension (PH) lead to arterial hypoxaemia.

Objective

To investigate whether cerebral tissue oxygenation (CTO) in patients with PH is reduced and whether this is associated with reduced exercise tolerance.

Methods

16 patients with PH (mean pulmonary arterial pressure ≥25 mmHg, 14 arterial, 2 chronic thromboembolic) and 15 controls underwent right heart catheterisation with monitoring of CTO at rest, during maximal bicycle exercise and during inhalation of oxygen and NO. The 6 min walk distance (6MWD) was measured.

Results

Median CTO in PH-patients at rest was 62 % (quartiles 53; 71), during exercise 60 % (53; 65); corresponding values in controls were 65 % (73; 73) (P = NS) and 68 % (66; 70) (p = .013 vs. PH). Inhalation of NO and oxygen improved CTO in PH. In multivariate regression analysis CTO at maximal exercise predicted the work load achieved when controlled for age, pulmonary vascular resistance and mixed venous oxygen saturation (R 2 = .419, p < .000); in addition, the 6MWD was predicted by CTO (adjusted R 2 = .511, p < .000).

Conclusion

In PH-patients but not in controls CTO decreased during exercise. Since CTO was an independent predictor of the work load achieved and the 6MWD cerebral hypoxia may contribute to exercise limitation in PH. Clinicaltrials.gov: NCT01463514.
Literature
1.
go back to reference Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 34:1219–1263PubMedCrossRef Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 34:1219–1263PubMedCrossRef
2.
go back to reference Simonneau G, Robbins IM, Beghetti M et al (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43–S54PubMedCrossRef Simonneau G, Robbins IM, Beghetti M et al (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43–S54PubMedCrossRef
3.
go back to reference Manier G, Castaing Y (1994) Contribution of multiple inert gas elimination technique to pulmonary medicine–4. Gas exchange abnormalities in pulmonary vascular and cardiac disease. Thorax 49(11):1169–1174PubMedCentralPubMedCrossRef Manier G, Castaing Y (1994) Contribution of multiple inert gas elimination technique to pulmonary medicine–4. Gas exchange abnormalities in pulmonary vascular and cardiac disease. Thorax 49(11):1169–1174PubMedCentralPubMedCrossRef
4.
go back to reference Barbosa PB, Ferreira EM, Arakaki JS et al (2011) Kinetics of skeletal muscle O2 delivery and utilization at the onset of heavy-intensity exercise in pulmonary arterial hypertension. Eur J Appl Physiol 111(8):1851–1861PubMedCrossRef Barbosa PB, Ferreira EM, Arakaki JS et al (2011) Kinetics of skeletal muscle O2 delivery and utilization at the onset of heavy-intensity exercise in pulmonary arterial hypertension. Eur J Appl Physiol 111(8):1851–1861PubMedCrossRef
5.
go back to reference Rooks CR, Thom NJ, McCully KK et al (2010) Effects of incremental exercise on cerebral oxygenation measured by near-infrared spectroscopy: a systematic review. Prog Neurobiol 92(2):134–150PubMedCrossRef Rooks CR, Thom NJ, McCully KK et al (2010) Effects of incremental exercise on cerebral oxygenation measured by near-infrared spectroscopy: a systematic review. Prog Neurobiol 92(2):134–150PubMedCrossRef
6.
go back to reference ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef
7.
go back to reference Moinard J, Manier G, Pillet O et al (1994) Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 149(6):1482–1487PubMedCrossRef Moinard J, Manier G, Pillet O et al (1994) Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 149(6):1482–1487PubMedCrossRef
8.
go back to reference Hildenbrand FF, Bloch KE, Speich R et al (2012) Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension. Respiration 84:477–484PubMedCrossRef Hildenbrand FF, Bloch KE, Speich R et al (2012) Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension. Respiration 84:477–484PubMedCrossRef
9.
go back to reference Ulrich S, Fischler M, Speich R et al (2008) Sleep-related breathing disorders in patients with pulmonary hypertension. Chest 133(6):1375–1380PubMedCrossRef Ulrich S, Fischler M, Speich R et al (2008) Sleep-related breathing disorders in patients with pulmonary hypertension. Chest 133(6):1375–1380PubMedCrossRef
10.
go back to reference Sun XG, Hansen JE, Oudiz RJ et al (2001) Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104(4):429–435PubMedCrossRef Sun XG, Hansen JE, Oudiz RJ et al (2001) Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104(4):429–435PubMedCrossRef
11.
go back to reference Matsuura C, Gomes PS, Haykowsky M et al (2011) Cerebral and muscle oxygenation changes during static and dynamic knee extensions to voluntary fatigue in healthy men and women: a near infrared spectroscopy study. Clin Physiol Funct Imaging 31(2):114–123PubMed Matsuura C, Gomes PS, Haykowsky M et al (2011) Cerebral and muscle oxygenation changes during static and dynamic knee extensions to voluntary fatigue in healthy men and women: a near infrared spectroscopy study. Clin Physiol Funct Imaging 31(2):114–123PubMed
12.
go back to reference Secher NH, Seifert T, Van Lieshout JJ (2008) Cerebral blood flow and metabolism during exercise: implications for fatigue. J Appl Physiol 104(1):306–314PubMedCrossRef Secher NH, Seifert T, Van Lieshout JJ (2008) Cerebral blood flow and metabolism during exercise: implications for fatigue. J Appl Physiol 104(1):306–314PubMedCrossRef
13.
go back to reference Bhambhani Y, Malik R, Mookerjee S (2007) Cerebral oxygenation declines at exercise intensities above the respiratory compensation threshold. Respir Physiol Neurobiol 156(2):196–202PubMedCrossRef Bhambhani Y, Malik R, Mookerjee S (2007) Cerebral oxygenation declines at exercise intensities above the respiratory compensation threshold. Respir Physiol Neurobiol 156(2):196–202PubMedCrossRef
14.
go back to reference Marshall HC, Hamlin MJ, Hellemans J et al (2008) Effects of intermittent hypoxia on SaO(2), cerebral and muscle oxygenation during maximal exercise in athletes with exercise-induced hypoxemia. Eur J Appl Physiol 104(2):383–393PubMedCrossRef Marshall HC, Hamlin MJ, Hellemans J et al (2008) Effects of intermittent hypoxia on SaO(2), cerebral and muscle oxygenation during maximal exercise in athletes with exercise-induced hypoxemia. Eur J Appl Physiol 104(2):383–393PubMedCrossRef
15.
go back to reference Jensen G, Nielsen HB, Ide K et al (2002) Cerebral oxygenation during exercise in patients with terminal lung disease. Chest 122(2):445–450PubMedCrossRef Jensen G, Nielsen HB, Ide K et al (2002) Cerebral oxygenation during exercise in patients with terminal lung disease. Chest 122(2):445–450PubMedCrossRef
16.
go back to reference Noakes TD, Peltonen JE, Rusko HK (2001) Evidence that a central governor regulates exercise performance during acute hypoxia and hyperoxia. J Exp Biol 204(Pt 18):3225–3234PubMed Noakes TD, Peltonen JE, Rusko HK (2001) Evidence that a central governor regulates exercise performance during acute hypoxia and hyperoxia. J Exp Biol 204(Pt 18):3225–3234PubMed
17.
go back to reference Vermeij A, van Beek AH, Olde Rikkert MG et al (2012) Effects of aging on cerebral oxygenation during working-memory performance: a functional near-infrared spectroscopy study. PLoS One 7(9):e46210PubMedCentralPubMedCrossRef Vermeij A, van Beek AH, Olde Rikkert MG et al (2012) Effects of aging on cerebral oxygenation during working-memory performance: a functional near-infrared spectroscopy study. PLoS One 7(9):e46210PubMedCentralPubMedCrossRef
18.
go back to reference Oussaidene K, Prieur F, Bougault V et al (2013) Cerebral oxygenation during hyperoxia-induced increase in exercise tolerance for untrained men. Eur J Appl Physiol 113(8):2047–2056PubMedCrossRef Oussaidene K, Prieur F, Bougault V et al (2013) Cerebral oxygenation during hyperoxia-induced increase in exercise tolerance for untrained men. Eur J Appl Physiol 113(8):2047–2056PubMedCrossRef
19.
go back to reference Kayser B, Narici M, Binzoni T et al (1994) Fatigue and exhaustion in chronic hypobaric hypoxia: influence of exercising muscle mass. J Appl Physiol (1985) 76(2):634–640 Kayser B, Narici M, Binzoni T et al (1994) Fatigue and exhaustion in chronic hypobaric hypoxia: influence of exercising muscle mass. J Appl Physiol (1985) 76(2):634–640
20.
go back to reference Jones AM, Burnley M (2009) Oxygen uptake kinetics: an underappreciated determinant of exercise performance. Int J Sports Physiol Perform 4(4):524–532PubMed Jones AM, Burnley M (2009) Oxygen uptake kinetics: an underappreciated determinant of exercise performance. Int J Sports Physiol Perform 4(4):524–532PubMed
21.
go back to reference Naeije R (2005) Breathing more with weaker respiratory muscles in pulmonary arterial hypertension. Eur Respir J 25(1):6–8PubMedCrossRef Naeije R (2005) Breathing more with weaker respiratory muscles in pulmonary arterial hypertension. Eur Respir J 25(1):6–8PubMedCrossRef
22.
go back to reference Noponen T, Nordh A, Berg A et al (2009) Circulatory effects of inhaled iloprost in the newborn preterm lamb. Pediatr Res 66(4):416–422PubMedCrossRef Noponen T, Nordh A, Berg A et al (2009) Circulatory effects of inhaled iloprost in the newborn preterm lamb. Pediatr Res 66(4):416–422PubMedCrossRef
23.
go back to reference Nagdyman N, Fleck T, Bitterling B et al (2006) Influence of intravenous sildenafil on cerebral oxygenation measured by near-infrared spectroscopy in infants after cardiac surgery. Pediatr Res 59(3):462–465PubMedCrossRef Nagdyman N, Fleck T, Bitterling B et al (2006) Influence of intravenous sildenafil on cerebral oxygenation measured by near-infrared spectroscopy in infants after cardiac surgery. Pediatr Res 59(3):462–465PubMedCrossRef
Metadata
Title
Effects of Exercise and Vasodilators on Cerebral Tissue Oxygenation in Pulmonary Hypertension
Authors
Séverine Müller-Mottet
Florian F. Hildenbrand
Stephan Keusch
Elisabeth Hasler
Marco Maggiorini
Rudolf Speich
Konrad E. Bloch
Silvia Ulrich
Publication date
01-02-2015
Publisher
Springer US
Published in
Lung / Issue 1/2015
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-014-9667-5

Other articles of this Issue 1/2015

Lung 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine